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Objective: Several studies report a higher prevalence of peripheral arterial disease (PAD) in women and among blacks.
These studies based their PAD definition on an ankle-brachial index (ABI) <0.90. We hypothesized that there is an
inherent contribution of gender and ethnicity to normal ABI values, independent of biologic and social disparities that
exist between gender and ethnic groups. Consequently, an ABI threshold that disregards these fundamental gender-
related and ethnicity-related differences could partly contribute to reported prevalence differences.
Methods:A cross-sectional study was designed as part of theMulti-Ethnic Study of Atherosclerosis (MESA), a multicenter
United States population study. We selected a subgroup of participants with unequivocally normal ABIs (1.00 to 1.30),
and additionally excluded participants with any major PAD risk factor (smoking, diabetes, dyslipidemia, hypertension).
In a linear model with ABI as the dependent variable, demographic, clinical, biologic, and social variables were introduced
as independent factors.
Results: Among 1775 healthy participants, there was no association between ABI level and subclinical cardiovascular
disease (coronary calcium or carotid plaque). Male gender, weight, and high education level were positively correlated
with ABI, whereas black race, triglycerides, pack-years (in past smokers), and pulse pressure were negatively correlated.
In the fully adjustedmodel, women had about 0.02 lower ABI values thanmen, and blacks showed ABI values about 0.02
lower than non-Hispanic whites.
Conclusion: These data suggest intrinsic ethnic and gender differences in ABI. Such differences, although small in
magnitude, are highly significant and can distort population estimates of disease burden. (J Vasc Surg 2007;45:319-27.)As a manifestation of atherosclerosis, peripheral ar-
terial disease (PAD) is associated with lower extremity
functional limitations, trophic complications, and an
increased risk for future cardiovascular events.1-6 Beyond
older age and male gender, the major risk factors con-
tributing to this condition are smoking, diabetes, and to
a lesser degree, hypertension and dyslipidemia.7,8 Be-
cause it also allows the detection of asymptomatic sub-
jects, epidemiologic studies in the last 20 years have
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doi:10.1016/j.jvs.2006.10.032typically based their definition of PAD on the ankle-
brachial index (ABI).3,5,6,8-15 Even at a subclinical level,
the presence of PAD defined by an abnormal ABI is a
reliable marker of future cardiovascular events.1-3,5,6
Hence, ABI measurement is of great clinical relevance
for the diagnosis of PAD as well as for the assessment of
cardiovascular risk.1,8
Recent estimates16,17 report a prevalence of 5 to 7
million adults in the United States population with PAD,
with higher rates among blacks compared with non-
Hispanic whites (NHWs). Despite the analysis of several
biologic and socioeconomic factors, this difference has not
been fully explained.11,13,16,18-21 More surprisingly, sev-
eral community-based surveys9,11,13,21 report higher rates
of PAD in women compared with men, even after adjusting
for age.11,21 This contrasts with what is generally accepted
about the prevalence of atherosclerotic diseases, where
women, especially until the seventh decade, present a lower
rate of cardiovascular diseases (CVD).22
Because the prevalence of PAD among gender and
ethnic groups is usually defined by a low ABI (0.90),
one might question whether ABI values in health are
similar within gender/ethnic groups and whether a sin-
gle threshold for all gender/ethnic groups is then appro-
priate. An earlier epidemiologic study reported lower
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obvious whether different ABI values observed in gen-
der/ethnic groups are actually related to differences in
the development of atherosclerosis in the lower limbs, or
whether some intrinsic anatomic or physiologic differ-
ences could partly affect these values. In a whole popu-
lation, after adjusting for different prevalence in CVD
risk factors in gender and ethnic groups, residual con-
founding and other biases might remain (eg, risk factor
management disparities between genders or across eth-
nic groups). Thus, to assess potential intrinsic differences
in ABI values appropriately, a healthy population free of
PAD and its modifiable risk factors is required.
In this cross-sectional study, focused on subjects free of
PAD, we hypothesized that even after adjustment for bio-
logic and social disparities between gender and ethnic
groups, an independent effect of these two characteristics
on the ABI would remain. If such a fundamental difference
between genders and ethnic groups existed, it might influ-
ence the gender and ethnic group disparities in PAD prev-
alence reported in the general population when a single
ABI threshold is used. The Multi-Ethnic Study on Athero-
sclerosis (MESA) provided a unique opportunity to explore
this hypothesis.
MATERIALS AND METHODS
Multi-Ethnic Study on Atherosclerosis population.
MESA was initiated by the National Heart, Lung and
Blood Institute to investigate the prevalence, correlates,
and progression of subclinical CVD in a multiethnic
population-based sample of 6814 men and women aged
45 to 84 years without a history of clinical CVD.24
Participants were selected between 2000 and 2002 from
six United States field centers: Baltimore City and Balti-
more County, Maryland; Chicago, Illinois; Forsyth
County, North Carolina; Los Angeles County, California;
Northern Manhattan and the Bronx, New York; and St.
Paul, Minnesota. The Institutional Review Boards at all
participating centers approved the study, and all partici-
pants gave informed consent. The study was designed to
include 38% NHWs, 28% blacks, 23% Hispanics, 11% of
Chinese descent, and approximately 50% women.
Study population (the healthy group). To deter-
mine the correlates of normal ABI values, we first defined a
subset of the MESA population with no evidence of PAD.
The normal range of ABI used as a starting point was
between 1.00 and 1.30. This was based on a previous
MESA publication showing a correlation with subclinical
coronary and carotid disease when ABI was 1.00 or
1.30.25 Because a normal ABI does not definitely exclude
the presence of PAD,16,26 we also excluded from the nor-
mal ABI group all participants at high risk of PAD based on
the presence of any major risk factor. Participants were
excluded if they were diabetic, hypertensive, a smoker, or
had dyslipidemia (defined in the next section). According
to these criteria, 1775 participants without any major riskfactor and an ABI of 1.00 to 1.30 constituted the healthy
PAD-free subgroup.
Definition of major risk factors. Participants were
considered smokers if they reported current cigarette smoking
or had stopped smoking within the last 2 years. Dyslipidemia
was defined by a total/high-density-lipoprotein cholesterol
ratio 5 or use of lipid-lowering agents.27 Diabetes was
defined by fasting blood glucose 1.26 g/L or use of
antidiabetic drugs.
Systolic and diastolic blood pressures (SBP, DBP) were
measured three times in the right arm of seated participants
with a Dinamap model Pro 100 automated oscillometric
sphygmomanometer (Critikon, Tampa, FL). The average
of the last two measurements was used in the analyses.
Participants were considered hypertensive if SBP was140
mm Hg or DBP90 mmHg, or both, or the subject both
self-reported a history of hypertension and was taking an-
tihypertensive drugs. We also analyzed the respective con-
tributions of the steady and pulsatile components of blood
pressure,28 expressed as the mean blood pressure (MBP 
2/3 DBP 1/3 SBP) and the pulse pressure (PP SBP –
DBP).
Laboratory variables. Laboratory variables were cen-
trally measured on blood collected from enrollees and
frozen at –70°C. The methods of measurements are de-
scribed elsewhere.23
Ankle-brachial index. After a 5-minute rest in a
supine position, SBPs were measured in both arms and in
the posterior tibial (PT) and dorsalis pedis (DP) arteries
of both ankles, using appropriate-sized cuffs and a con-
tinuous wave Doppler probe. The ABI was computed
separately for each leg, with the numerator the highest of
the PT or DP systolic pressures and the denominator the
highest of the right vs left brachial systolic pressures. The
index ABI for the participant was the lower of the right vs
left ABI.
Subclinical disease measures. Computed tomogra-
phy imaging of the coronary arteries was performed as
previously described.24,29,30 We defined the presence of
subclinical coronary disease by the presence of any cor-
onary calcification (CAC score 0). Carotid ultrasound
imaging protocol has been described elsewhere.24,25 The
images were analyzed off-line for the presence of carotid
plaque, defined as any focal thickening of the carotid wall
in the carotid bulbs or internal carotid arteries. Subclin-
ical atherosclerotic disease was defined by the presence of
any subclinical coronary disease or carotid plaque.
Statistical methods. Categoric and continuous vari-
ables were compared across race/ethnic groups within each
gender using 2 tests and analysis of variance, respectively.
Log-transformation was used as needed to stabilize variance
before comparison of the means. Log-transformed variables
were back-transformed for tabular presentation, but statistical
testing was performed on the log-transformed values. Distri-
butions of ABIs within each gender and race subgroupwere
compared by box-plots, as defined by Tukey.31 The novel
risk factors selected here were based on a previous study of
risk factors for PAD in MESA.18 A series of linear regression
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gender and race associations with ABI within the group free
of major PAD risk factors and normal ABI of 1.00 to 1.30.
Each model adjusted for progressively more potential con-
founders. For all the tests, a P  .05 was considered as
significant.
RESULTS
Table I presents the eight gender/ethnic subgroups
of this study population. As determined by the National
Cholesterol Education Program calculation of the Fra-
mingham score,32 the average 10-year risk of CHD in
this subgroup was very low, at 4.2%, despite the older age
of participants. Compared with the excluded MESA
participants, this population presented low levels not
only of variables related to the traditional risk factors
(cholesterol ratio, blood pressure, blood glucose) but
also of other potential risk factors (data not shown). This
population also presented with a lower prevalence of
subclinical atherosclerotic disease, which was uniformly
distributed within the ABI range (data not shown). The
Figure displays the ABI distribution across the eight sex
and ethnic groups. Higher ABI values were noted in men
vs women. Overall, ABI values were lower in blacks than
other ethnic groups.
In a first linear regression (model 1) including age,
female gender, and ethnicity, the age and gender were
negatively correlated with the ABI (Table II). Compared
with NHWs, being black or Chinese was significantly asso-
ciated with lower ABI values. There was no evidence of
interactions between these variables; that is, the association
of female gender with lower ABI did not differ by age or
ethnicity, nor did the association of ethnicity with ABI
differ by age or gender.
In the second regression (model 2), demographic vari-
ables, and traditional and novel CVD risk factors as well as
the presence or absence of subclinical atherosclerotic dis-
ease were added to model 1. Despite a comprehensive
inclusion of all potential confounders, the association of
female gender with lower ABI in this normal range, al-
though attenuated, remained significant, whereas the sig-
nificantly lower ABI in blacks compared with NHWs was
essentially unchanged. The association of Chinese ethnicity
with lower ABI was weakened after adjustment and became
nonsignificant.
In addition, a high level of education and weight were
positively correlated with ABI, whereas triglycerides, pack-
years (in former smokers), and pulse pressure were nega-
tively correlated. Notably, height did not show any signif-
icant correlation with PAD in this fully adjusted model; it
was significantly correlated with ABI when adjusted only
for age, ethnicity, and gender (data not shown).
Of interest was that none of the novel risk factors
associated with PAD in the whole MESA population18
showed any significant correlation with ABI in this healthy
group. Similar results were found when the analysis wasfocused on a subgroup of 945 participants without any
subclinical atherosclerosis (data not shown).
To estimate the effect in the MESA population, we
compared the standard PAD definition of an ABI 0.90
with a gender/ethnic specific use of threshold, taking the
group of NHW men arbitrarily as reference (with the
0.90 cutpoint) and calculating the other thresholds (ie,
0.88 in NHW women) in the other groups according to
fully adjusted differences obtained in Table II. The prev-
alence of PAD in NHW women would decrease from
3.5% with the standard cutpoint to 2.2% when the spe-
cific threshold was used, and the women/men ratio in
NHWs would invert from 1.25 to 0.79. Similarly, the
prevalence of PAD in black women would decrease from
6.4% to 4.1%, with a women/men ratio in blacks chang-
ing from 1.05 to 0.75. Regarding ethnic disparities, the
ratio for black/NHW men at 2.17 with standard defini-
tion would decrease to 1.96. In other terms, compared
with NHW men, the standard PAD definition would
overestimate PAD prevalence in NHW women by 37%,
black men by 10%, and black women by 36%.
DISCUSSION
In this cross-sectional study focused on a subgroup of
the MESA population without PAD or major risk factors,
we found that even after extensive covariate adjustment,
ABI varied across genders and ethnic groups, being higher
in men than women, and higher NHWs than in blacks.
Peripheral arterial disease definition in epidemio-
logic studies. Inmost epidemiologic studies, an ABI0.90
is used as a single criterion to define PAD.3,5,10,12-15,21,33
This cutpoint is generally accepted on the basis of a clinical
study comparing ABI 0.90 with arteriography, with a
90% sensitivity and 95% specificity to detect 50% arterial
stenosis.34 Correcting this for verification bias, Lijmer
et al35 reported a sensitivity of 79% and specificity of 96%.
These results were obtained in clinical samples, however,
and the actual diagnostic value of this threshold in the
general population including different ethnic groups is
unclear. In the San Diego Population Study,16 33 (19.6%)
of 168 legs with PAD presented a normal ABI (ie,0.90),
and the disease was detected by abnormal posterior tibial
artery Doppler waveforms.
This is to emphasize that the use of ABI 0.90 as the
sole criteria for PAD does not exclude false negatives. In
addition, even when ABI is assessed in a clinical population
vs arteriography, in infrequent but not negligible cases, an
ABI 0.90 leads falsely to consider a subject with normal
(or 50% stenosis) angiography as having PAD.
Ankle-brachial index in healthy subjects. Paradox-
ically, the normal values of ABI in healthy participants
are poorly studied. In subjects without any peripheral
arterial stenosis, the ABI is 1.00 and 1.30. The
physiologic increase in ankle systolic pressures compared
with brachial arterial pressures is related to the pulse
amplitude increase as a pulse travels from the aorta
toward the periphery. The increase is proportional to the
Table I. Description of the Multi-Ethnic Study of Atherosclerosis population subset without evidence of peripheral arterial disease (n  1775)
Men
P
Women
P
NHW
(n  318)
Blacks
(n  150)
Hispanics
(n  159)
Chinese
(n  121)
NHW
(n  453)
Blacks
(n  187)
Hispanics
(n226)
Chinese
(n161)
Age (yrs) 60.2 (9.8) 58.4 (9.8) 59.2 (10.3) 59.1 (10.4) .29 59.3 (9.9) 57.3 (8.9) 56.9 (9.6) 57.9 (9.6) .006
Weight (kg) 84.2 (14.0) 88.2 (14.6) 79.9 (13.1) 65.2 (9.7) .001 69.7 (13.9) 80.0 (16.5) 70.4 (13.4) 56.9 (8.5) .001
Height (cm) 177.0 (7.2) 177.1 (6.2) 169.5 (6.0) 168.5 (6.5) .001 163.5 (6.3) 162.9 (7.0) 156.2 (6.1) 156.4 (5.6) .001
Former smoker 157 (49.7) 70 (47.6) 78 (49.4) 41 (33.9) .022 205 (45.6) 61 (32.6) 53 (23.6) 1 (0.6) .001
Pack-years 12.1 (21.0) 8.3 (14.6) 10.0 (20.9) 4.8 (12.3) .003 7.4 (13.6) 4.7 (11.4) 1.9 (8.6) 0.0 (0.1) .001
Blood glucose* (g/L) 0.95 (0.09) 0.96 (0.10) 0.97 (0.09) 0.98 (0.09) .003 0.90 (0.09) 0.92 (0.10) 1.08 (0.37) 0.95 (0.08) .001
Total/HDL-C 3.9 (0.7) 3.6 (0.8) 4.0 (0.7) 3.7 (0.8) .001 3.4 (0.8) 3.3 (0.8) 3.7 (0.7) 3.6 (0.7) .001
Triglycerides* (g/L) 0.98 (0.43) 0.83 (0.35) 1.19 (0.62) 1.06 (0.58) .001 1.07 (0.52) 0.80 (0.33) 1.22 (0.58) 1.20 (0.59) .001
SBP (mm Hg) 115.5 (11.7) 118.1 (12.2) 116.3 (11.5) 113.3 (12.5) .01 111.0 (13.8) 117.5 (12.1) 112.3 (13.1) 111.1 (14.2) .001
DBP (mm Hg) 71.4 (8.1) 74.2 (7.3) 72.4 (7.0) 71.6 (7.9) .003 63.8 (8.0) 69.9 (7.8) 68.4 (9.6) 65.7 (8.5) .001
MBP (mm Hg) 86.1 (8.5) 88.8 (8.1) 87.0 (7.4) 85.5 (8.7) .003 79.5 (8.7) 85.8 (8.1) 80.8 (8.9) 80.8 (9.2) .001
PP (mm Hg) 44.1 (9.1) 43.9 (9.5) 44.0 (9.8) 41.7 (8.6) .08 47.2 (11.8) 47.6 (10.2) 47.2 (10.7) 45.4 (11.6) .25
Heart rate (bpm) 59.7 (8.8) 59.9 (9.3) 61.3 (8.9) 62.1 (7.7) .027 62.9 (8.1) 63.0 (8.0) 63.2 (8.1) 64.0 (8.3) .56
Education
High school 3 (1.0) 12 (8.1) 62 (39.0) 16 (13.2) 14 (3.1) 10 (5.4) 88 (38.9) 43 (26.7)
High school 92 (29.2) 71 (48.0) 66 (41.5) 37 (30.6) .001 183 (40.5) 96 (51.3) 115 (50.9) 70 (43.5) .001
College degree 88 (27.9) 31 (20.9) 18 (11.3) 35 (28.9) 125 (27.7) 41 (21.9) 12 (5.3) 35 (21.7)
Graduate school 132 (41.9) 34 (23.0) 13 (8.2) 33 (27.3) 130 (28.8) 40 (21.4) 11 (4.9) 13 (8.1)
Total house income
$25k 17 (5.5) 22 (15.6) 61 (38.6) 55 (45.5) 58 (13.0) 38 (21.1) 108 (49.1) 73 (45.9)
$25k-$49k 68 (22.1) 36 (25.5) 56 (35.4) 26 (21.5) .001 129 (29.0) 56 (31.1) 74 (33.6) 35 (22.0) .001
$50k-$99k 108 (35.1) 62 (44.0) 35 (22.2) 22 (18.2) 149 (33.5) 63 (35.0) 35 (15.9) 33 (20.7)
$100k 115 (37.3) 21 (14.9) 6 (3.8) 18 (14.9) 109 (24.5) 23 (12.8) 3 (1.4) 18 (11.3)
CRP* (mg/L) 1.8 (3.4) 2.5 (4.3) 2.6 (3.9) 1.7 (8.9) .001 3.7 (6.2) 4.8 (8.0) 4.8 (6.0) 1.5 (2.9) .001
IL-6* (mg/L) 1.2 (1.2) 1.3 (1.0) 1.5 (1.2) 1.0 (1.0) .001 1.2 (1.0) 1.4 (0.9) 1.5 (1.0) 0.9 (0.7) .001
Fibrinogen (mg/mL) 3.1 (0.6) 3.1 (0.6) 3.3 (0.7) 2.9 (0.5) .001 3.3 (0.7) 3.6 (0.8) 3.6 (0.7) 3.3 (0.5) .001
PAP* (nM) 4.3 (1.5) 4.7 (1.7) 4.3 (1.7) 4.0 (1.5) .002 5.1 (2.0) 5.3 (2.0) 4.8 (2.1) 4.0 (1.4) .001
D-dimers* (g/mL) 0.2 (0.2) 0.3 (0.4) 0.3 (0.4) 0.3 (0.8) .12 0.3 (0.4) 0.4 (0.7) 0.4 (1.4) 0.2 (0.3) .001
Homocysteine* (mol/L) 9.6 (3.1) 10.2 (4.5) 9.3 (2.2) 9.0 (1.9) .01 8.2 (5.6) 8.1 (2.2) 7.6 (2.6) 7.4 (1.8) .001
CAC 0 174 (54.7) 45 (30.0) 70 (44.0) 49 (40.5) .001 119 (26.3) 32 (17.1) 36 (15.9) 43 (26.7) .003
Carotid lesions 105 (33.4) 29 (19.9) 50 (32.1) 16 (13.3) .001 134 (30.3) 43 (23.6) 38 (17.4) 26 (16.2) .001
ABI 1.16 (0.06) 1.14 (0.07) 1.16 (0.06) 1.14 (0.06) .003 1.13 (0.07) 1.11 (0.06) 1.12 (0.06) 1.11 (0.06) .003
NHW, Non-Hispanic whites; HDL-C, High-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; PP, pulse pressure; CRP, C-reactive protein; IL,
interleukin; PAP, plasmin-antiplasmin complex; CAC, coronary artery calcification; ABI, ankle-brachial index.
Numbers are mean (standard deviation) for continuous variables or n (%) for categoric variables.
*Indicates that significance was tested on natural log transformed scale.
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ankle than brachial arteries.36
Gender differences in ankle-brachial index. In an
ancillary study from the San Luis Valley Diabetes Study,
Hiatt et al23 analyzed the ABI distribution in a subgroup of
nonsmokers without glucose intolerance, blood pressure
140/90 mm Hg, or any CVD history. This subgroup
presented 2.5th percentile values at 0.91 for women and
0.98 for men. It has been suggested that the lower ABI
among women is related to a lower height,33 leading to a
lesser pulse amplification; however, after adjustments for
age, sex, arm pressure, and diabetes status, the contribution
of height to ABI turned to be modest, about 1 mm Hg
ankle pressure increase for each 10 cm in height.23 In a
population without clinical CVD, London et al37 reported
a positive correlation between body height and ABI, but
women showed a lower ABI even after adjustments for age
Table II. Correlates of ankle-brachial index in healthy sub
Mod
coefficient
Age (10 years) 0.008 (0.
Female gender 0.036 (0.
Ethnicity
Non-Hispanic white Ref
Black 0.017 (0.
Hispanic 0.002 (0.
Chinese 0.020 (0.
Weight (per kg) —
Height (per cm) —
Ever smoking —
Pack-years (per unit) —
Glucose* (g/L) —
Total/HDL-C —
Triglycerides* (g/L) —
MBP (per mm Hg) —
PP (per mm Hg) —
Heart rate (per bpm) —
Education
High school
Completed high school —
College
Graduate school
Income
$25k
$25k-$49k —
$50k-$99k
$100k
Hs-CRP* (mg/L) —
IL-6* (mg/L) —
Fibrinogen (per mg/mL) —
PAP* (nM) —
D-dimers* (g/mL) —
Homocysteine* (mol/L) —
CAC 0 —
Carotid lesions —
HDL-C,High-density lipoprotein cholesterol;MBP,mean blood pressure; P
plasmin-antiplasmin complex; CAC, coronary artery calcification.
*P  .05.
†P  .01.
‡P  .001.
*Units that are natural log-transformed.and height.We initially found a significant correlation between
height and ABI adjusted for age, gender, and ethnicity,
but we did not find height as an independent significant
determinant of ABI in healthy participants in the fully
adjusted model. The adjusted contribution of height to
ABI seems negligible. According to its partial coefficient,
ABI was an average of 0.003 units higher for every 10 cm
more height.
Our data suggest that the ABI is about 0.02 lower in
women than men. Consequently, a unisex ABI threshold
used for PAD definition might partially explain higher
rates of PAD in women.11,13,21 This is consistent with
data from the San Diego Population Study,16 a popula-
tion study where the PAD definition included an ABI
0.90 as well as other criteria (abnormal Doppler wave-
forms and revascularization history). In this population,
a lower ABI was reported for women (1.12 vs 1.16 for
(linear regression models)
CI)
Model 2
coefficient (95% CI)
0.005) 0.002 (0.007, 0.002)
0.030) 0.017† (0.027, 0.006)
Ref
0.009) 0.019‡ (0.029, 0.010)
.006) 0.008 (0.002, 0.019)
0.011) 0.007 (0.019, 0.004)
0.0006‡ (0.0003, 0.0009)
0.0003 (0.0003, 0.0009)
0.004 (0.004, 0.012)
0.0004† (0.0006, 0.0001)
0.0347 (0.0007, 0.0701)
0.0044 (0.0006, 0.0094)
0.0102* (0.0186, 0.0017)
0.0001 (0.0005, 0.0003)
0.0005† (0.0009, 0.0001)
0.0004 (0.0008, 0.0001)
Ref
0.006 (0.004, 0.017)
0.008 (0.005, 0.020)
0.021† (0.008, 0.033)
Ref
0.001 (0.008, 0.009)
0.002 (0.012, 0.007)
0.004 (0.015, 0.008)
0.0022 (0.0058, 0.0014)
0.0003 (0.0060, 0.0055)
0.0000 (0.0001, 0.0001)
0.0006 (0.0111, 0.0098)
0.0006 (0.0046, 0.0034)
0.0098 (0.0028, 0.0222)
0.003 (0.011, 0.004)
0.001 (0.008, 0.007)
se pressure; hs-CRP, high-sensitive C-reactive protein; IL, interleukin; PAP,jects
el 1
(95%
01, 
042, 
026, 
010, 0
028, 
P, pulmen). This suggests a shift to lower ABI values for
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rate of low (0.90) ABI values in women. When PAD
was defined by several criteria, however, higher rates of
PAD were reported in men.16 In the National Health
and Nutrition Examination Survey (NHANES)13 and
Atherosclerosis Risk in Communities (ARIC)21 reports,
the prevalence of ABI 0.90 in women aged 40 to 59
years was intriguingly estimated to be about twice as
high as in men. In the ARIC study,21 in contrast to
higher prevalence of PAD in women when ABI thresh-
olds were fixed at 0.95 or 0.90, men had higher rates of
PAD when lower thresholds were used (0.85 or 0.80).
Ethnic differences in peripheral arterial disease
rates. In clinical series, PAD in blacks is reported as
more frequent,38 more severe,39,40 and with poorer out-
come.39,41-45 Nonetheless, the higher prevalence of dia-
betes11,21,46 and hypertension11,21,47 in blacks, as well as
social disparities (eg, different accessibility to medical care),
may contribute to outcome. Furthermore, this higher rate
of PAD does not adequately match with a higher rate of
clinical symptoms. In a study48 mixing one community-
dwelling population and two vascular laboratory popula-
tions, the most severe pain categories (eg, typical intermit-
tent claudication) were significantly less common in blacks.
Recent data also showed no increased rates of functional
decline in blacks vs whites with PAD.49 Two conclusions
can be made:
First, black subjects could present clinical symptoms in
a more progressed stage of the disease. This is plausible
since PAD affects more distal arteries50 in blacks, and the
rates of diabetes and neuropathy are higher in this ethnic
group.10,40 This could result in delayed medical care and
worse prognosis. Alternatively, but not exclusively, this
could also indicate that a similar low level of ABI does not
reflect an equivalent extent of the disease in whites and in
Fig. Box plot of ankle-brachial index (ABI) by gender and race/
ethnicity in participants without peripheral arterial disease or risk
factors. Bullets correspond to individual cases beyond the standard
deviation. Data are presented with standard deviation. NHW,
Non-Hispanic whites; AS, Chinese; AA, blacks; HSP, Hispanics.blacks. The latter explanation is concordant with our find-ings that even in healthy subjects, ABI is lower in blacks
compared with whites.
Similarly, population-based studies report higher
rates of PAD in blacks, even after adjustments for tradi-
tional and novel risk factors as well as socioeconomic
status.10,13,16,18,20,21 The San Diego population study16
excluded a greater susceptibility of blacks to PAD risk
factors, after testing interaction terms between ethnicity
and nine major risk factors. It is of interest that when
different ABI thresholds were used in the ARIC study,21
from 0.80 to 0.95, the ratio of black/NHW males of
age-adjusted PAD prevalence decreased from 2.2 to 1.2.
This may suggest that PAD in blacks is more severe, or this
could partly be due to the different distribution of ABI in
ethnic groups, as observed here. The approximately 0.02
difference between NHWs and blacks in our study is similar
to that observed after adjustment for age, gender, and
height in the ARIC study.21
Regarding the other ethnic groups, the NHANES
reported10,13 a trend to a higher adjusted-rate of PAD in
Mexican Americans. In MESA18, adjusted for age, gen-
der, education, income, and traditional risk factors, the
prevalence of an ABI 0.90 was significantly lower in
Chinese Americans and Hispanics. We found a different
ABI distribution in healthy Chinese and Hispanics vs
NHW (Fig), but this difference was strongly attenuated
by adjustments. We conclude that unlike our findings in
blacks, differences observed in healthy Chinese and His-
panic subjects are mainly related to different distribu-
tions of risk factors.
Biologic explanations. The basic difference on ABI
values in different gender/ethnic groups without PAD
must be related to other conditions than atherosclerosis.
The pressure amplification from the central to peripheral
arteries depends on the arterial geometry and elasticity
variations between the aorta and the site of measure-
ment.36 Aortic stiffening causes premature return of the
pulse wave reflection from the periphery, which dimin-
ishes until eliminating the normal augmentation of the
pressure waveform from central to peripheral arteries,28
such as the brachial artery, and even more to ankle
arteries, leading to an ABI reduction. The ABI, conse-
quently, is affected both by the presence of any (athero-
sclerotic) obstruction and by the aortic and peripheral
stiffness.
Using magnetic resonance imaging in a subset of the
MESA population, a thicker thoracic aorta was reported
among blacks.51 In middle age, the aorta in blacks is
stiffer than in whites.52 This is due to a higher aortic
collagen concentration.53 Notably, this effect is visible in
our study, as pulse pressure, an indirect marker of large-
vessels stiffness,54 was inversely correlated with ABI.
This was also reported in the Cardiovascular Health
Study.55 Even though aortic stiffening is of major prog-
nostic importance,56 this is a different pathology from
PAD.
Other correlates of normal ankle-brachial index.
Among other significant contributors to ABI determina-
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Volume 45, Number 2 Aboyans et al 325tion in this study, a high level of education was consistently
correlated with a higher ABI. Similarly, a higher education
level is protective for PAD in the entire MESA popula-
tion.18 Despite a similar trend, this was not confirmed in
the San Diego Population Study,16 but it could be related
to the concomitant inclusion of the type of occupation
in that predictive model, a variable that we did not test.
Education may index other behavioral and socioeconomic
factors not assessed in this study.
Study implications. The residual effect of gender
and ethnicity in our fully adjusted model could at the first
glance be considered as negligible. At an individual scale,
a 0.02 ABI difference between men and women or
whites and blacks is quite below the ABI measurement
variability.56,57 Henceforth, the single 0.90 ABI thresh-
old for the diagnosis of PAD remains valid in the clinical
setting, even though our data could be useful in some
borderline ABI values, especially in black women.
At a population level, however, a small change in ABI
threshold affects substantially the estimates of disease burden.
The women/men ratios in blacks and whites inverted 1
when gender/ethnic specific thresholds were used vs the
unique 0.90 cutpoint. Similarly, the prevalence of PAD in
blacks, especially in women, would substantially be lower with
this new approach, and the disparities with whites, although
remaining consistent, would be reduced at some extent.
Study limitations. Among other potential corre-
lates, lipoprotein (a) was not available in this study.
Furthermore, hormonal and genetic data were not stud-
ied. We cannot exclude their role (or that of other
unknown risk factors) as confounding factors in these
analyses. It seems unlikely, however, that the addition of
one or more additional covariates would remove the
gender and ethnic differences observed given the exten-
sive adjustment we have already incorporated. In addi-
tion, we did not find any correlation in this healthy
population between ABI and subclinical atherosclerosis
in other territories. This reduces the risk of missing
unknown risk factors of atherosclerosis that could ex-
plain gender/ethnic disparities on normal ABI values.
CONCLUSION
To our knowledge, this is the first multiethnic study
to assess the contribution of gender and ethnicity to the
determination of ABI in low-risk subjects with no evi-
dence of PAD. Our main results confirm the hypothesis
that even after extensive control of confounders, gender
and ethnicity remain independently associated with ABI.
This suggests that some inherent physiologic (eg, hor-
monal, genetic) differences in ABI normal levels exist
between different gender/ethnic groups. We consider
that such differences, although small in magnitude, are
highly statistically significant and can distort population
estimates of disease burden.AUTHOR CONTRIBUTIONS
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